231 related articles for article (PubMed ID: 26062903)
1. Antibiotic use for Vibrio infections: important insights from surveillance data.
Wong KC; Brown AM; Luscombe GM; Wong SJ; Mendis K
BMC Infect Dis; 2015 Jun; 15():226. PubMed ID: 26062903
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and antibiotics in Vibrio vulnificus septicemia.
Liu JW; Lee IK; Tang HJ; Ko WC; Lee HC; Liu YC; Hsueh PR; Chuang YC
Arch Intern Med; 2006 Oct; 166(19):2117-23. PubMed ID: 17060542
[TBL] [Abstract][Full Text] [Related]
3. Increasing rates of vibriosis in the United States, 1996-2010: review of surveillance data from 2 systems.
Newton A; Kendall M; Vugia DJ; Henao OL; Mahon BE
Clin Infect Dis; 2012 Jun; 54 Suppl 5(0 5):S391-5. PubMed ID: 22572659
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Third-Generation Cephalosporin Plus Ciprofloxacin or Doxycycline Therapy in Patients with Vibrio vulnificus Septicemia: A Propensity Score-Matched Analysis.
Kim SE; Shin SU; Oh TH; Kim UJ; Darboe KS; Kang SJ; Jang HC; Jung SI; Shin HY; Park KH
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007478. PubMed ID: 31188821
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance trends among
Morgado ME; Brumfield KD; Chattopadhyay S; Malayil L; Alawode T; Amokeodo I; He X; Huq A; Colwell RR; Sapkota AR
Appl Environ Microbiol; 2024 Jun; 90(6):e0053924. PubMed ID: 38809043
[TBL] [Abstract][Full Text] [Related]
6. Vibrio vulnificus infection: a persistent threat to public health.
Yun NR; Kim DM
Korean J Intern Med; 2018 Nov; 33(6):1070-1078. PubMed ID: 29898575
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance of Vibrio parahaemolyticus and Vibrio vulnificus in various countries: A review.
Elmahdi S; DaSilva LV; Parveen S
Food Microbiol; 2016 Aug; 57():128-34. PubMed ID: 27052711
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Ceftriaxone, Cefepime, Doxycycline, Ciprofloxacin, and Combination Therapy for Vibrio vulnificus Foodborne Septicemia.
Trinh SA; Gavin HE; Satchell KJF
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971862
[TBL] [Abstract][Full Text] [Related]
9. Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997-2006.
Dechet AM; Yu PA; Koram N; Painter J
Clin Infect Dis; 2008 Apr; 46(7):970-6. PubMed ID: 18444811
[TBL] [Abstract][Full Text] [Related]
10. Vibrio vulnificus septicaemia.
Sie MY; Ip-yam PC; Oon LL
Anaesth Intensive Care; 2002 Feb; 30(1):77-81. PubMed ID: 11939447
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period.
Chen SC; Lee YT; Tsai SJ; Chan KS; Chao WN; Wang PH; Lin DB; Chen CC; Lee MC
J Antimicrob Chemother; 2012 Feb; 67(2):488-93. PubMed ID: 22117030
[TBL] [Abstract][Full Text] [Related]
12. [Vibrio vulnificus infections].
Fujiyama S; Tanaka M
Nihon Naika Gakkai Zasshi; 1998 May; 87(5):934-40. PubMed ID: 9648448
[No Abstract] [Full Text] [Related]
13. Quantitative PCR and in vivo efficacy of antibiotics in the treatment of Vibrio vulnificus infection in a mouse model.
Neupane GP; Kim DM; Yun NR; Shin SH; Lim SC; Choi CH
Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2461-7. PubMed ID: 22434454
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline.
Bowdre JH; Hull JH; Cocchetto DM
J Pharmacol Exp Ther; 1983 Jun; 225(3):595-8. PubMed ID: 6864521
[TBL] [Abstract][Full Text] [Related]
15. Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015.
Dengo-Baloi LC; Semá-Baltazar CA; Manhique LV; Chitio JE; Inguane DL; Langa JP
PLoS One; 2017; 12(8):e0181496. PubMed ID: 28792540
[TBL] [Abstract][Full Text] [Related]
16. Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.
Lee JK; Lee S; Hong SK; Byun SS; Lee SE
BMC Urol; 2016 Aug; 16(1):51. PubMed ID: 27557527
[TBL] [Abstract][Full Text] [Related]
17. Vibrio vulnificus infection reporting on death certificates: the invisible impact of an often fatal infection.
Banatvala N; Hlady WG; Ray BJ; McFarland LM; Thompson S; Tauxe RV
Epidemiol Infect; 1997 Jun; 118(3):221-5. PubMed ID: 9207732
[TBL] [Abstract][Full Text] [Related]
18. Vibrio vulnificus endometritis.
Tison DL; Kelly MT
J Clin Microbiol; 1984 Aug; 20(2):185-6. PubMed ID: 6490813
[TBL] [Abstract][Full Text] [Related]
19. Non-O1, non-O139 Vibrio cholerae bacteremic skin and soft tissue infections.
Maraki S; Christidou A; Anastasaki M; Scoulica E
Infect Dis (Lond); 2016; 48(3):171-6. PubMed ID: 26503346
[TBL] [Abstract][Full Text] [Related]
20. Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis.
Chao WN; Tsai CF; Chang HR; Chan KS; Su CH; Lee YT; Ueng KC; Chen CC; Chen SC; Lee MC
Am J Surg; 2013 Jul; 206(1):32-9. PubMed ID: 23414632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
